Quality of life of the cancer patients with the target therapy induced dermatologic toxicities

Quality of life of the cancer patients with the target therapy induced dermatologic toxicities - Quality of life of the cancer patients with the target therapy induced dermatologic toxicities

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000024377

Enrollment

100

Registered

2016-11-01

Start date

2016-11-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Patient with the target therapy induced dermatologic toxicities (CTCAE Grade 1 or more), 2)Stage and metastasis are no object, 3)Patient who is able to complete to the questionnaire in Japanese, 4)Patient aged 20 or more (no upper age limit).

Exclusion criteria

Exclusion criteria: 1)Patient decided by primary doctor that it's difficult to participate in the research because of current severer physical pain, anxiety, or depression, 2)ECOG performance status of 3 or more, 3)Patient cognitive impairment or mental disorders.

Design outcomes

Primary

Measure	Time frame
Health related quality of life:EQ-5D, DLQI(Dermatology Life Quality Index)	—

Secondary

Measure	Time frame
Depression and Anxiety: K6 The Mental Adjustment to Cancer scale (MAC)	—

Countries

Japan

Contacts

Public ContactKaori Yagasaki

Keio University Faculty of Nursing and Medical Care

yagasaki@sfc.keio.ac.jp03-5363-2157

Outcome results